Annual Cash & Cash Equivalents:
$139.04M-$4.90M(-3.41%)Summary
- As of today, TSHA annual cash & cash equivalents is $139.04 million, with the most recent change of -$4.90 million (-3.41%) on December 31, 2024.
- During the last 3 years, TSHA annual cash & cash equivalents has fallen by -$10.07 million (-6.75%).
- TSHA annual cash & cash equivalents is now -44.66% below its all-time high of $251.25 million, reached on December 31, 2020.
Performance
TSHA Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$297.79M-$15.42M(-4.92%)Summary
- As of today, TSHA quarterly cash & cash equivalents is $297.79 million, with the most recent change of -$15.42 million (-4.92%) on September 30, 2025.
- Over the past year, TSHA quarterly cash & cash equivalents has increased by +$139.66 million (+88.31%).
- TSHA quarterly cash & cash equivalents is now -4.92% below its all-time high of $313.21 million, reached on June 30, 2025.
Performance
TSHA Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TSHA Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -3.4% | +88.3% |
| 3Y3 Years | -6.8% | +768.0% |
| 5Y5 Years | +100.0% | +6.9% |
TSHA Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -6.8% | +58.2% | -4.9% | +768.0% |
| 5Y | 5-Year | -44.7% | >+9999.0% | -4.9% | +768.0% |
| All-Time | All-Time | -44.7% | >+9999.0% | -4.9% | +2558.9% |
TSHA Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $297.79M(-4.9%) |
| Jun 2025 | - | $313.21M(+167.6%) |
| Mar 2025 | - | $117.04M(-16.1%) |
| Dec 2024 | $139.04M(-3.4%) | $139.49M(-11.8%) |
| Sep 2024 | - | $158.14M(-8.7%) |
| Jun 2024 | - | $173.19M(+39.2%) |
| Mar 2024 | - | $124.43M(-13.8%) |
| Dec 2023 | $143.94M(+63.8%) | $144.39M(-12.1%) |
| Sep 2023 | - | $164.28M(+264.4%) |
| Jun 2023 | - | $45.08M(-28.9%) |
| Mar 2023 | - | $63.42M(-27.8%) |
| Dec 2022 | $87.88M | $87.88M(+156.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $34.31M(-48.2%) |
| Jun 2022 | - | $66.24M(-31.5%) |
| Mar 2022 | - | $96.63M(-35.2%) |
| Dec 2021 | $149.10M(-40.7%) | $149.10M(-21.0%) |
| Sep 2021 | - | $188.78M(-4.3%) |
| Jun 2021 | - | $197.37M(-13.7%) |
| Mar 2021 | - | $228.68M(-9.0%) |
| Dec 2020 | $251.25M(>+9900.0%) | - |
| Dec 2020 | - | $251.25M(-9.8%) |
| Sep 2020 | - | $278.63M(+2387.8%) |
| Jun 2020 | - | $11.20M |
| Dec 2019 | $0.00 | - |
FAQ
- What is Taysha Gene Therapies, Inc. annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. annual cash & cash equivalents year-on-year change?
- What is Taysha Gene Therapies, Inc. quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Taysha Gene Therapies, Inc.?
- What is Taysha Gene Therapies, Inc. quarterly cash & cash equivalents year-on-year change?
What is Taysha Gene Therapies, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of TSHA is $139.04M
What is the all-time high annual cash & cash equivalents for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high annual cash & cash equivalents is $251.25M
What is Taysha Gene Therapies, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, TSHA annual cash & cash equivalents has changed by -$4.90M (-3.41%)
What is Taysha Gene Therapies, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of TSHA is $297.79M
What is the all-time high quarterly cash & cash equivalents for Taysha Gene Therapies, Inc.?
Taysha Gene Therapies, Inc. all-time high quarterly cash & cash equivalents is $313.21M
What is Taysha Gene Therapies, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, TSHA quarterly cash & cash equivalents has changed by +$139.66M (+88.31%)